Leopard Asset Management Urges Sun Corporation’s Shareholders to Hold Management Accountable for Their Failure to Achieve Their Own Stated Goals of Increasing Shareholder Value
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $12.00 to $14.00. They now have an "overweight" rating on the stock.
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Needham & Company LLC from $13.50 to $14.00. They now have a "buy" rating on the stock.
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
Cellebrite Announces First-Quarter 2024 Results [Yahoo! Finance]